{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:19:43Z","timestamp":1790860783981,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1023\/a:1006462023110","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:03:28Z","timestamp":1040522608000},"page":"241-247","source":"Crossref","is-referenced-by-count":16,"title":["Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer"],"prefix":"10.1007","volume":"61","author":[{"given":"A.","family":"Zambelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Robustelli della Cuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ponchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A. Da","family":"Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Robustelli della Cuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"269880_CR1","first-page":"464","volume":"23","author":"G Bonadonna","year":"1996","unstructured":"Bonadonna G, Valagussa P: Primary chemotherapy in operable breast cancer. Semin Oncol 23: 464\u2013474, 1996","journal-title":"Semin Oncol"},{"key":"269880_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0959-8049(95)00612-5","volume":"32A","author":"G Bonadonna","year":"1996","unstructured":"Bonadonna G: Current and future trends in the multidisciplinary approach of high-risk breast cancer: the experience of the Milan Cancer Institute. Eur J Cancer 32A: 209\u2013214, 1996","journal-title":"Eur J Cancer"},{"key":"269880_CR3","first-page":"101a","volume":"17","author":"IC Henderson","year":"1998","unstructured":"Henderson IC, Berry D, Demetri G, Cirrincione C, Goldstein L, Martino S, Ingle JN, Cooper MR, Canellos G, Borden E, Fleming G, Holland JF, Graziano S, Carpenter J, Muss H, Norton L: Improved disease-free and overall survival from the addition of sequential paclitaxel, but not from the escalation of doxorubicin dose level in the adjuvant chemotherapy of patients with node positive primary breast cancer. Proc Am Soc Clin Oncol 17: 101a, Abstr 390A, 1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"269880_CR4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1200\/JCO.1993.11.6.1132","volume":"11","author":"WP Peters","year":"1993","unstructured":"Peters WP, Ross M, Vredenburg JJ, Meisenberg B, Marks LB, Winer E, Kurtzeberg J, Bast RC jr, Jones R, Shpall E, Wu K, Rosner G, Gilbert C, Mathias B, Coniglio D, Petros W, Craig Henderson I, Norton L, Weiss R, Budman D, Hurd D: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose therapy for high-risk primary breast cancer. J Clin Oncol 11: 1132\u20131143, 1993","journal-title":"J Clin Oncol"},{"key":"269880_CR5","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1200\/JCO.1997.15.6.2312","volume":"15","author":"AM Gianni","year":"1997","unstructured":"Gianni AM, Siena S, Bregni M, Di Nicola M, Orefice S, Cusumano F, Salvadori B, Luini A, Greco M, Zucali R, Rilke F, Zambetti M, Valagussa P, Bonadonna G: Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five year results. J Clin Oncol 15: 2312\u20132321, 1997","journal-title":"J Clin Oncol"},{"key":"269880_CR6","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1995.13.10.2483","volume":"13","author":"WR Bezwoda","year":"1995","unstructured":"Bezwoda WR, Seymour L, Dansey RD: High-dose chemotherapy with hematopoletic rescue as primary treatment for metastatic breast cancer: a randomized clinical trial. J Clin Oncol 13: 2483\u20132489, 1995","journal-title":"J Clin Oncol"},{"issue":"Suppl.3","key":"269880_CR7","first-page":"1","volume":"20","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Eisenhauer EA, Chauadrhy U, Arbuck S, Donehower CR: Paclitaxel (Taxol) Investigators' Workshop. Semin Oncol 20(Suppl. 3): 1\u201360, 1993","journal-title":"Semin Oncol"},{"issue":"Suppl.4","key":"269880_CR8","first-page":"1","volume":"22","author":"MS Aapro","year":"1995","unstructured":"Aapro MS, Lavelle F, Bissery MC, Ravdin P, Fossella F, Kaye SB: The impact of docetaxel (Taxotere) on current treatment. Semin Oncol 22(Suppl. 4): 1\u201333, 1995","journal-title":"Semin Oncol"},{"issue":"Suppl.5","key":"269880_CR9","first-page":"1","volume":"22","author":"MD Abeloff","year":"1995","unstructured":"Abeloff MD, Hayes DF, Henderson IC: The current status of vinorelbine (Navelbine) in breast cancer. Semin Oncol 22 (Suppl. 5): 1\u201387, 1995","journal-title":"Semin Oncol"},{"key":"269880_CR10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/oxfordjournals.annonc.a058873","volume":"5","author":"M Degardin","year":"1994","unstructured":"Degardin M, Bonneterre J, Hecquet B, Pion JM, Adenis H, Homer D, Demaille A: Vinorelbine (Navelbine) as salvage treatment of advanced breast cancer. Ann Oncol 5: 423\u2013426, 1994","journal-title":"Ann Oncol"},{"key":"269880_CR11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/07357909109039875","volume":"9","author":"RM Hansen","year":"1991","unstructured":"Hansen RM: 5-fluorouracil by protracted intravenous infusion: a review of recent clinical studies. Cancer Invest 9: 637\u2013642, 1991","journal-title":"Cancer Invest"},{"key":"269880_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0305-7372(94)90017-5","volume":"20","author":"JS Ng","year":"1994","unstructured":"Ng JS, Cameron DA, Leonard RCF: Infusional 5-fluorouracil in breast cancer. Cancer Treat Rev 20: 357\u2013364, 1994","journal-title":"Cancer Treat Rev"},{"key":"269880_CR13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO;2-F","volume":"39","author":"JL Hayward","year":"1977","unstructured":"Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A, Ruben RD: Assessment of response to therapy in advanced breast cancer. Cancer 39: 1289\u20131294, 1977","journal-title":"Cancer"},{"key":"269880_CR14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM197902083000603","volume":"300","author":"J Alexander","year":"1979","unstructured":"Alexander J, Dainiak N, Berger HJ, Goldman L, Johnstone D, Reduto L, Dufty T, Schwartz P, Gottschalk A, Zaret B: Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide cardioangiography. N Engl J Med 300: 278\u2013283, 1979","journal-title":"N Engl J Med"},{"key":"269880_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 207\u2013214, 1981","journal-title":"Cancer"},{"key":"269880_CR16","first-page":"185","volume":"135","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Nonparametric estimation for incomplete observation. J Am Stat Assoc 135: 185\u2013198, 1958","journal-title":"J Am Stat Assoc"},{"key":"269880_CR17","first-page":"187","volume":"34","author":"R Peto","year":"1972","unstructured":"Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J P Stat Soc(A) 34: 187\u2013220, 1972","journal-title":"J P Stat Soc(A)"},{"key":"269880_CR18","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/bjc.1997.231","volume":"75","author":"P Pedrazzoli","year":"1997","unstructured":"Pedrazzoli P, Perotti C, Da Prada GA, Battaglia M, Pavesi L, Preti P, Salvaneschi L, Robustelli della Cuna G: Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer. Br J Cancer 75: 1368\u20131379, 1997","journal-title":"Br J Cancer"},{"key":"269880_CR19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199810013391407","volume":"339","author":"GN Hortobagyi","year":"1998","unstructured":"Hortobagyi GN: Treatment of breast cancer. N Engl J Med 339: 974\u2013984, 1998","journal-title":"N Engl J Med"},{"key":"269880_CR20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","volume":"332","author":"EK Rowinsky","year":"1995","unstructured":"Rowinsky EK, Donehower RC: Paclitaxel (Taxol). N Engl J Med 332: 1004\u20131014, 1995","journal-title":"N Engl J Med"},{"key":"269880_CR21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","volume":"339","author":"PK Singal","year":"1998","unstructured":"Singal PK, Iliskovic N: Doxorubicin-induced cardiomiopathy. N Engl J Med 339: 900\u2013905, 1998","journal-title":"N Engl J Med"},{"issue":"Suppl7","key":"269880_CR22","first-page":"19","volume":"21","author":"L Norton","year":"1994","unstructured":"Norton L: Salvage chemotherapy of breast cancer. Semin Oncol 21 (Suppl 7): 19\u201324, 1994","journal-title":"Semin Oncol"},{"key":"269880_CR23","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1200\/JCO.1996.14.12.3097","volume":"14","author":"V Dieras","year":"1996","unstructured":"Dieras V, Extra LM, Bellisant E, Espie M, Morvan F, Pierga JY, Mignot L, Tresca P, Marty M: Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method. J Clin Oncol 14: 3097\u20133104, 1996","journal-title":"J Clin Oncol"},{"key":"269880_CR24","first-page":"91","volume":"14","author":"M Vogel","year":"1995","unstructured":"Vogel M, Hochster H, Blumreich M, Davis H, Graham M, Fabian C, Laufman L, Steinfeldt H, Hohneker J: A US multicenter phase II study of iv Navelbine (NVB) and 5 fluorouracil (5FU) as first line treatment of patients with advanced breast cancer (ABC). Proc Am Soc Clin Oncol 14: 91, Abstract 62, 1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"269880_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1005769604001","volume":"44","author":"M Zambetti","year":"1997","unstructured":"Zambetti M, Demicheli R, De Candis D, Antonelli G, Terenziani M, Laifranchi A, Garbagnati F, Biasi S, Bonadonna G: Five-day infusion fluorouracil plus vinorelbine iv in metastatic pretreated breast cancer. Breast Cancer Res Treat 44: 255\u2013260, 1997","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006462023110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006462023110\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006462023110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006462023110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:17:27Z","timestamp":1750479447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006462023110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["269880"],"URL":"https:\/\/doi.org\/10.1023\/a:1006462023110","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}